2型糖尿病对乳腺癌发生、发展的相关性研究现状
Research Status of the Correlation between Type 2 Diabetes Mellitus and the Occurrence and Development of Breast Cancer
DOI: 10.12677/ACM.2022.124434, PDF,   
作者: 李 聪, 吴耀禄*：延安大学附属医院，陕西 延安
关键词: 乳腺癌；2型糖尿病；相关性；Breast Cancer； Type 2 Diabetes Mellitus； Correlation
摘要: 随着我国人民饮食方式、生活环境的改变，乳腺癌和糖尿病已成为当前威胁人类生命健康的两大常见疾病。一些临床数据资料显示，糖尿病尤其是2型糖尿病患者中乳腺癌的发病率逐年在增加，乳腺癌患者中往往同时合并有2型糖尿病，因此，乳腺癌与2型糖尿病之间的关系也逐渐引起人们的重视，但关于二者之间的作用机制仍存在争议。本文对近年来关于乳腺癌与2型糖尿病关系的流行病学研究以及2型糖尿病对乳腺癌发生、发展之间的可能影响作一综述。
Abstract: With the changes of people’s diet and living environment in my country, breast cancer and diabetes have become two common diseases that threaten human life and health. Some clinical data show that the incidence of breast cancer in patients with diabetes, especially type 2 diabetes mellitus, is increasing year by year, and breast cancer patients often have type 2 diabetes mellitus at the same time. Therefore, the relationship between breast cancer and type 2 diabetes mellitus is gradually caused people’s attention, but the mechanism of action between the two is still controversial. This article reviews recent epidemiological studies on the relationship between breast cancer and type 2 diabetes mellitus and the possible impact of type 2 diabetes mellitus on the occurrence and development of breast cancer.
文章引用：李聪, 吴耀禄. 2型糖尿病对乳腺癌发生、发展的相关性研究现状[J]. 临床医学进展, 2022, 12(4): 3010-3017. https://doi.org/10.12677/ACM.2022.124434

参考文献

[1] Hu, K., Ding, P., Wu, Y., et al. (2019) Global Patterns and Trends in the Breast Cancer Incidence and Mortality According to Sociodemographic Indices: An Observational Study Based on the Global Burden of Diseases. BMJ Open, 9, e28461. [Google Scholar] [CrossRef] [PubMed]
[2] Ferlay, J., Colombet, M., Soerjomataram, I., et al. (2021) Cancer Statistics for the Year 2020: An Overview. International Journal of Cancer, 149, 778-789. [Google Scholar] [CrossRef] [PubMed]
[3] Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. [Google Scholar] [CrossRef] [PubMed]
[4] Widschwendter, P., Friedl, T.W., Schwentner, L., et al. (2015) The Influence of Obesity on Survival in Early, High-Risk Breast Cancer: Results from the Randomized SUCCESS A Trial. Breast Cancer Research, 17, 129. [Google Scholar] [CrossRef] [PubMed]
[5] He, D.E., Bai, J.W., Liu, J., et al. (2015) Clinicopathological Characteristics and Prognosis of Breast Cancer Patients with Type 2 Diabetes Mellitus. Molecular and Clinical Oncology, 3, 607-612. [Google Scholar] [CrossRef] [PubMed]
[6] Lega, I.C., Austin, P.C., Fischer, H.D., et al. (2018) The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study. Diabetes Care, 41, 755-761. [Google Scholar] [CrossRef] [PubMed]
[7] 乔晓娟, 李昊昌, 李云霞, 等. 内蒙古地区女性乳腺癌与2型糖尿病关系的回顾性分析[J]. 中国医药科学, 2013, 3(22): 161-162.
[8] 朱晴晴. 2型糖尿病对乳腺癌患者病情发展及淋巴结转移的影响[J]. 航空航天医学杂志, 2021, 32(4): 408-409.
[9] Smiley, D. and Umpierrez, G.E. (2010) Management of Hyperglycemia in Hospitalized Patients. Annals of the New York Academy of Sciences, 1212, 1-11. [Google Scholar] [CrossRef] [PubMed]
[10] Ziech, D., Franco, R., Georgakilas, A.G., et al. (2010) The Role of Reactive Oxygen Species and Oxidative Stress in Environmental Carcinogenesis and Biomarker Development. Chemico-Biological Interactions, 188, 334-339. [Google Scholar] [CrossRef] [PubMed]
[11] Kellenberger, L.D., Bruin, J.E., Greenaway, J., et al. (2010) The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer. Journal of Oncology, 2010, Article ID: 514310. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, Y., Zhu, Y.D., Gui, Q., et al. (2014) Glucagon-Induced Angiogenesis and Tumor Growth through the HIF-1-VEGF-Dependent Pathway in Hyperglycemic Nude Mice. Genetics and Molecular Research, 13, 7173-7183. [Google Scholar] [CrossRef] 
[13] Lopez, R., Arumugam, A., Joseph, R., et al. (2013) Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR. PLoS ONE, 8, e79708. [Google Scholar] [CrossRef] [PubMed]
[14] Alisson-Silva, F., Freire-de-Lima, L., Donadio, J.L., et al. (2013) Increase of O-Glycosylated Oncofetal Fibronectin in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Epithelial Cells. PLoS ONE, 8, e60471. [Google Scholar] [CrossRef] [PubMed]
[15] Flores-López, L.A., Martínez-Hernández, M.G., Viedma-Rodríguez, R., et al. (2016) High Glucose and Insulin Enhance uPA Expression, ROS Formation and Invasiveness in Breast Cancer-Derived Cells. Cellular Oncology, 39, 365-378. [Google Scholar] [CrossRef] [PubMed]
[16] Viedma-Rodríguez, R., Martínez-Hernández, M.G., Flores-López, L.A., et al. (2018) Epsilon-Aminocaproic Acid Prevents High Glucose and Insulin Induced-Invasiveness in MDA-MB-231 Breast Cancer Cells, Modulating the Plasminogen Activator System. Molecular and Cellular Biochemistry, 437, 65-80. [Google Scholar] [CrossRef] [PubMed]
[17] Zielinska, H.A., Holly, J.M.P., Bahl, A., et al. (2018) Inhibition of FASN and ERα Signalling during Hyperglycaemia-Induced Matrix-Specific EMT Promotes Breast Cancer Cell Invasion via a Caveolin-1-Dependent Mechanism. Cancer Letters, 419, 187-202. [Google Scholar] [CrossRef] [PubMed]
[18] Adham, S.A., Al, R.H., Habib, S., et al. (2014) Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules. PLoS ONE, 9, e113103. [Google Scholar] [CrossRef] [PubMed]
[19] Gajeton, J., Krukovets, I., Muppala, S., et al. (2021) Hyperglycemia-Induced miR-467 Drives Tumor Inflammation and Growth in Breast Cancer. Cancers, 13, 1346. [Google Scholar] [CrossRef] [PubMed]
[20] Saltiel, A.R., Kahn, C.R. (2001) Insulin Signalling and the Regulation of Glucose and Lipid Metabolism. Nature, 414, 799-806. [Google Scholar] [CrossRef] [PubMed]
[21] Engelman, J.A., Luo, J. and Cantley, L.C. (2006) The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism. Nature Reviews Genetics, 7, 606-619. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, A.M.Y., Wellberg, E.A., Kopp, J.L., et al. (2021) Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes & Metabolism Journal, 45, 285-311. [Google Scholar] [CrossRef] [PubMed]
[23] LeRoith, D. and Roberts, C.T. (2003) The Insulin-Like Growth Factor System and Cancer. Cancer Letters, 195, 127-137. [Google Scholar] [CrossRef] 
[24] Cascio, S., Bartella, V., Auriemma, A., et al. (2008) Mechanism of Leptin Expression in Breast Cancer Cells: Role of Hypoxia-Inducible Factor-1. Oncogene, 27, 540-547. [Google Scholar] [CrossRef] [PubMed]
[25] Cordero-Franco, H.F., Salinas-Martínez, A.M., Abundis, A., et al. (2014) The Effect of Insulin Resistance on Breast Cancer Risk in Latinas of Mexican Origin. Metabolic Syndrome and Related Disorders, 12, 477-483. [Google Scholar] [CrossRef] [PubMed]
[26] Murphy, N., Knuppel, A., Papadimitriou, N., et al. (2020) Insulin-Like Growth Factor-1, Insulin-Like Growth Factor-Binding Protein-3, and Breast Cancer Risk: Observational and Mendelian Randomization Analyses with ~430,000 Women. Annals of Oncology, 31, 641-649. [Google Scholar] [CrossRef] [PubMed]
[27] De, Vincenzo, A., Belli, S., Franco, P., et al. (2019) Paracrine Recruitment and Activation of Fibroblasts by c-Myc Expressing Breast Epithelial Cells through the IGFs/IGF-1R Axis. International Journal of Cancer, 145, 2827-2839. [Google Scholar] [CrossRef] [PubMed]
[28] Bates, P., Fisher, R., Ward, A., et al. (1995) Mammary Cancer in Transgenic Mice Expressing Insulin-Like Growth Factor II (IGF-II). British Journal of Cancer, 72, 1189-1193. [Google Scholar] [CrossRef] [PubMed]
[29] Tworoger, S.S., Eliassen, A.H., Kelesidis, T., et al. (2007) Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer. The Journal of Clinical Endocrinology & Metabolism, 92, 1510-1516. [Google Scholar] [CrossRef] [PubMed]
[30] Taliaferro-Smith, L., Nagalingam, A., Knight, B.B., et al. (2013) Integral Role of PTP1B in Adiponectin-Mediated Inhibition of Oncogenic Actions of Leptin in Breast Carcinogenesis. Neoplasia, 15, 11-23. [Google Scholar] [CrossRef] [PubMed]
[31] Dos, S.E., Benaitreau, D., Dieudonne, M.N., et al. (2008) Adiponectin Mediates an Antiproliferative Response in Human MDA-MB 231 Breast Cancer Cells. Oncology Reports, 20, 971-977.
[32] Taliaferro-Smith, L., Nagalingam, A., Zhong, D., et al. (2009) LKB1 Is Required for Adiponectin-Mediated Modulation of AMPK-S6K Axis and Inhibition of Migration and Invasion of Breast Cancer Cells. Oncogene, 28, 2621-2633. [Google Scholar] [CrossRef] [PubMed]
[33] 沈丽, 段卫明, 陶敏. 乳腺癌与糖尿病关联研究的新进展[J]. 现代仪器与医疗, 2014, 20(1): 17-21.
[34] Pham, D. and Park, P. (2022) Adiponectin Triggers Breast Cancer Cell Death via Fatty Acid Metabolic Reprogramming. Journal of Experimental & Clinical Cancer Research, 41, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[35] Pan, H., Deng, L., Cui, J., et al. (2018) Association between Serum Leptin Levels and Breast Cancer Risk. Medicine, 97, e11345. [Google Scholar] [CrossRef] 
[36] Niu, J., Jiang, L., Guo, W., et al. (2013) The Association between Leptin Level and Breast Cancer: A Meta-Analysis. PLoS ONE, 8, e67349. [Google Scholar] [CrossRef] [PubMed]
[37] And, Ã.S., Barone, I., Giordano, C., et al. (2014) The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Frontiers in Oncology, 4, Article No. 340. [Google Scholar] [CrossRef] [PubMed]
[38] Wu, L., Chen, G., Liu, W., et al. (2017) Intramuscular Injection of Exogenous Leptin Induces Adiposity, Glucose Intolerance and Fatty Liver by Repressing the JAK2-STAT3/PI3K Pathway in a Rat Model. General and Comparative Endocrinology, 252, 88-96. [Google Scholar] [CrossRef] [PubMed]
[39] Mahbouli, S., Der Vartanian, A., Ortega, S., et al. (2017) Leptin Induces ROS via NOX5 in Healthy and Neoplastic Mammary Epithelial Cells. Oncology Reports, 38, 3254-3264. [Google Scholar] [CrossRef] [PubMed]
[40] Nepal, S., Jin, K.M., Hong, J.T., et al. (2015) Autophagy Induction by Leptin Contributes to Suppression of Apoptosis in Cancer Cells and Xenograft Model: Involvement of p53/FoxO3A Axis. Oncotarget, 6, 7166-7181. [Google Scholar] [CrossRef] [PubMed]
[41] Li, K., Wei, L., Huang, Y., et al. (2016) Leptin Promotes Breast Cancer Cell Migration and Invasion via IL-18 Expression and Secretion. International Journal of Oncology, 48, 2479-2487. [Google Scholar] [CrossRef] [PubMed]
[42] Dalamaga, M., Sotiropoulos, G., Karmaniolas, K., et al. (2013) Serum Resistin: A Biomarker of Breast Cancer in Postmenopausal Women? Association with Clinicopathological Characteristics, Tumor Markers, Inflammatory and Metabolic Parameters. Clinical Biochemistry, 46, 584-590. [Google Scholar] [CrossRef] [PubMed]
[43] Lee, Y., Chen, Y., Wu, C., et al. (2012) Resistin Expression in Breast Cancer Tissue as a Marker of Prognosis and Hormone Therapy Stratification. Gynecologic Oncology, 125, 742-750. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, C., Wang, P., Hsieh, Y., et al. (2018) Resistin Facilitates Breast Cancer Progression via TLR4-Mediated Induction of Mesenchymal Phenotypes and Stemness Properties. Oncogene, 37, 589-600. [Google Scholar] [CrossRef] [PubMed]
[45] Deshmukh, S.K., Srivastava, S.K., Bhardwaj, A., et al. (2015) Resistin and Interleukin-6 Exhibit Racially-Disparate Expression in Breast Cancer Patients, Display Molecular Association and Promote Growth and Aggressiveness of Tumor Cells through STAT3 Activation. Oncotarget, 6, 11231-11241. [Google Scholar] [CrossRef] [PubMed]
[46] Lee, J.O., Kim, N., Lee, H.J., et al. (2016) Resistin, a Fat-Derived Secretory Factor, Promotes Metastasis of MDA-MB-231 Human Breast Cancer Cells through ERM Activation. Scientific Reports, 6, Article No. 18923. [Google Scholar] [CrossRef] [PubMed]
[47] Yu, H., Lee, H., Herrmann, A., et al. (2014) Revisiting STAT3 Signalling in Cancer: New and Unexpected Biological Functions. Nature Reviews Cancer, 14, 736-746. [Google Scholar] [CrossRef] [PubMed]
[48] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef] 
[49] Kim, G., Ouzounova, M., Quraishi, A.A., et al. (2015) SOCS3-Mediated Regulation of Inflammatory Cytokines in PTEN and p53 Inactivated Triple Negative Breast Cancer Model. Oncogene, 34, 671-680. [Google Scholar] [CrossRef] [PubMed]
[50] Chang, S. and Yang, W.V. (2016) Hyperglycemia, Tumorigenesis, and Chronic Inflammation. Critical Reviews in Oncology/Hematology, 108, 146-153. [Google Scholar] [CrossRef] [PubMed]

为你推荐